Prime Capital Investment Advisors LLC purchased a new position in shares of Colgate-Palmolive (NYSE:CL) during the 1st quarter, according to its most recent 13F filing with the SEC. The firm purchased 4,300 shares of the company’s stock, valued at approximately $295,000.
A number of other institutional investors and hedge funds also recently bought and sold shares of CL. Capital Financial Planning LLC bought a new stake in shares of Colgate-Palmolive in the 4th quarter worth approximately $27,000. Timber Creek Capital Management LLC lifted its stake in shares of Colgate-Palmolive by 247.1% in the 4th quarter. Timber Creek Capital Management LLC now owns 472 shares of the company’s stock valued at $28,000 after purchasing an additional 336 shares during the period. Parisi Gray Wealth Management lifted its stake in shares of Colgate-Palmolive by 365.3% in the 4th quarter. Parisi Gray Wealth Management now owns 470 shares of the company’s stock valued at $28,000 after purchasing an additional 369 shares during the period. Portfolio Solutions LLC purchased a new position in shares of Colgate-Palmolive in the 4th quarter valued at approximately $30,000. Finally, WP Advisors LLC purchased a new position in shares of Colgate-Palmolive in the 1st quarter valued at approximately $34,000. Institutional investors and hedge funds own 76.27% of the company’s stock.
CL stock opened at $69.04 on Wednesday. Colgate-Palmolive has a 1-year low of $57.41 and a 1-year high of $72.61. The company has a debt-to-equity ratio of 32.25, a current ratio of 1.14 and a quick ratio of 0.76. The firm has a market capitalization of $59.36 billion, a PE ratio of 23.25, a price-to-earnings-growth ratio of 4.51 and a beta of 0.79.
Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, January 25th. The company reported $0.74 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.73 by $0.01. Colgate-Palmolive had a return on equity of 25,268.29% and a net margin of 15.44%. The firm had revenue of $3.81 billion during the quarter, compared to analysts’ expectations of $3.78 billion. During the same quarter in the previous year, the business earned $0.75 earnings per share. The company’s revenue was down 2.1% on a year-over-year basis. As a group, research analysts anticipate that Colgate-Palmolive will post 2.83 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be paid a $0.43 dividend. The ex-dividend date is Wednesday, April 17th. This represents a $1.72 annualized dividend and a dividend yield of 2.49%. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.42. Colgate-Palmolive’s payout ratio is currently 56.57%.
In other news, CFO Henning I. Jakobsen sold 969 shares of the business’s stock in a transaction on Tuesday, February 19th. The stock was sold at an average price of $66.39, for a total value of $64,331.91. Following the completion of the transaction, the chief financial officer now owns 35,208 shares in the company, valued at $2,337,459.12. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Ian M. Cook sold 17,750 shares of the business’s stock in a transaction on Friday, March 29th. The stock was sold at an average price of $67.37, for a total value of $1,195,817.50. Following the completion of the transaction, the chief executive officer now owns 1,130,793 shares of the company’s stock, valued at approximately $76,181,524.41. The disclosure for this sale can be found here. Insiders sold 85,450 shares of company stock valued at $5,682,621 in the last 90 days. Company insiders own 1.14% of the company’s stock.
A number of research firms have recently commented on CL. Zacks Investment Research cut Colgate-Palmolive from a “buy” rating to a “sell” rating in a research note on Monday. UBS Group raised their target price on Colgate-Palmolive from $71.00 to $75.00 and gave the company a “buy” rating in a research note on Friday, March 29th. Citigroup set a $68.00 target price on Colgate-Palmolive and gave the company a “hold” rating in a research note on Tuesday, March 19th. BNP Paribas upgraded Colgate-Palmolive from an “underperform” rating to a “neutral” rating and lifted their price objective for the company from $56.00 to $67.00 in a research note on Monday, February 11th. Finally, Credit Suisse Group initiated coverage on Colgate-Palmolive in a research note on Wednesday, March 6th. They set an “underperform” rating for the company. Three research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and four have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of $65.73.
ILLEGAL ACTIVITY NOTICE: “Prime Capital Investment Advisors LLC Purchases New Stake in Colgate-Palmolive (CL)” was first posted by Macon Daily and is the sole property of of Macon Daily. If you are reading this story on another site, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright laws. The legal version of this story can be read at https://macondaily.com/2019/04/17/prime-capital-investment-advisors-llc-purchases-new-stake-in-colgate-palmolive-cl.html.
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.
Featured Article: Different Types of Derivatives
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.